Literature DB >> 8880946

The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain.

J Maj1, M Bijak, M Dziedzicka-Wasylewska, R Rogoz, Z Rogóz, G Skuza, T Tokarski.   

Abstract

Effects of paroxetine (10 mg/kg PO, twice daily, 14 days) on 5-HT receptor subpopulations in the brain were evaluated pharmacologically, electrophysiologically and biochemically in male Wistar rats. Imipramine was used for comparison. Repeated paroxetine antagonized the 8-OH-DPAT-induced behavioural syndrome (a 5-HT1A effect); imipramine showed similar, yet weaker, activity. The 5-HT-or 8-OH-DPAT-induced inhibition of population spikes in hippocampal slices was increased by both those repeated antidepressants. Repeated (or acute) paroxetine decreased the density of and increased the affinity for 5-HT1A receptors ([3H]-8-OH-DPAT used as ligand) in the hippocampus, while imipramine induced opposite effects. m-Chlorophenyl piperazine (m-CPP)-evoked exploratory hypoactivity, a 5-HT2C effect, was reduced by repeated paroxetine, but not by imipramine. Either of the antidepressants given repeatedly antagonized TFMPP-induced hyperthermia (another putative 5-HT2C effect). 5-HTP-induced head twitches (a 5-HT2A effect) were inhibited by repeated paroxetine or imipramine. Either antidepressant given repeatedly decreased the density of 5-HT2A receptors ([3H]-ketanserin as a ligand) in the brain cortex, but did not change their affinity. The present results indicate that paroxetine given repeatedly induces secondary changes in 5-HT2 receptors, which lead to reduction of the 5-HT2 neurotransmission (reduced responsiveness of 5-HT2 postsynaptic receptors). The consequences of the secondary changes in 5-HT1A receptors, found here still await clarification.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880946     DOI: 10.1007/bf02805977

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  50 in total

1.  Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. IV. Influence of haloperidol (R 1625) and of chlorpromazine on the behaviour of rats in an unfamiliar "open field" situation.

Authors:  P A JANSSEN; A H JAGENEAU; K H SCHELLEKENS
Journal:  Psychopharmacologia       Date:  1960-09-13

2.  Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor.

Authors:  D R Thomas; D R Nelson; A M Johnson
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine.

Authors:  D T Wong; J S Horng; F P Bymaster; K L Hauser; B B Molloy
Journal:  Life Sci       Date:  1974-08-01       Impact factor: 5.037

4.  Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding.

Authors:  S J Peroutka; S H Snyder
Journal:  Science       Date:  1980-10-03       Impact factor: 47.728

5.  Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain.

Authors:  K J Kellar; C S Cascio; J A Butler; R N Kurtzke
Journal:  Eur J Pharmacol       Date:  1981-02-19       Impact factor: 4.432

6.  Effects of fluoxetine given chronically on the responsiveness of 5-HT receptor subpopulations to their agonists.

Authors:  J Maj; E Moryl
Journal:  Eur Neuropsychopharmacol       Date:  1993-06       Impact factor: 4.600

7.  5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice.

Authors:  G M Goodwin; A R Green; P Johnson
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

8.  Exploratory hypoactivity induced by m-trifluoromethylphenylpiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP).

Authors:  A Kłodzińska; T Jaros; E Chojnacka-Wójcik; J Maj
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1989

9.  Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.

Authors:  G A Kennett; G Curzon
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

10.  A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine.

Authors:  S J CORNE; R W PICKERING; B T WARNER
Journal:  Br J Pharmacol Chemother       Date:  1963-02
View more
  9 in total

Review 1.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

2.  Regulation of rat cortical 5-hydroxytryptamine2A receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramine.

Authors:  Gerard J Marek
Journal:  Eur Neuropsychopharmacol       Date:  2008-02-21       Impact factor: 4.600

3.  Time trial performance in normal and high ambient temperature: is there a role for 5-HT?

Authors:  Bart Roelands; Maaike Goekint; Luk Buyse; Frank Pauwels; Guy De Schutter; Francesca Piacentini; Hiroshi Hasegawa; Phil Watson; Romain Meeusen
Journal:  Eur J Appl Physiol       Date:  2009-06-17       Impact factor: 3.078

4.  Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors.

Authors:  N Haddjeri; P Blier; C de Montigny
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

5.  Cerebral 5-HT2A receptor binding, but not mGluR2, is increased in tryptophan hydroxylase 2 decrease-of-function mice.

Authors:  Christinna V Jørgensen; Jacob P Jacobsen; Marc G Caron; Anders B Klein; Gitte M Knudsen; Jens D Mikkelsen
Journal:  Neurosci Lett       Date:  2013-09-17       Impact factor: 3.046

6.  Adaptive changes in the reactivity of 5-HT1A and 5-HT2 receptors induced in rat frontal cortex by repeated imipramine and citalopram.

Authors:  Bartosz Bobula; Krzysztof Tokarski; Agnieszka Zahorodna; Grzegorz Hess
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-17       Impact factor: 3.000

7.  Effects of chronic antidepressant use on neurophysiological responses to tDCS post-stroke.

Authors:  Xin Li; Susanne M Morton
Journal:  Neurosci Lett       Date:  2019-12-24       Impact factor: 3.046

Review 8.  From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment.

Authors:  Chiara Fabbri; Stefano Porcelli; Alessandro Serretti
Journal:  Can J Psychiatry       Date:  2014-02       Impact factor: 4.356

Review 9.  Genetic Factors Affecting Seasonality, Mood, and the Circadian Clock.

Authors:  Corrado Garbazza; Francesco Benedetti
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-23       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.